ATYR Financial Statements

Balance sheet, income statement, cash flow, and dividends for Atyr Pharma Inc (ATYR).


$303.87M Market Cap.

As of 03/13/2025 5:00 PM ET (MRY) • Disclaimer

ATYR Market Cap. (MRY)


ATYR Shares Outstanding (MRY)


ATYR Assets (MRY)


Total Assets

$96.83M

Total Liabilities

$27.00M

Total Investments

$61.07M

ATYR Income (MRY)


Revenue

$235.00K

Net Income

-$64.02M

Operating Expense

$68.15M

ATYR Cash Flow (MRY)


CF Operations

-$69.12M

CF Investing

$17.23M

CF Financing

$39.86M

ATYR Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ATYR Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$96,830,000 (-19.75%)

$120,653,000 (25.96%)

$95,786,000 (-17.09%)

$115,537,000 (198.34%)

Assets Current

$81,954,000 (-20.43%)

$102,992,000 (27.35%)

$80,871,000 (-28.79%)

$113,569,000 (219.63%)

Assets Non-Current

$14,876,000 (-15.77%)

$17,661,000 (18.41%)

$14,915,000 (657.88%)

$1,968,000 (-38.40%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$70,019,000 (-22.77%)

$90,658,000 (26.86%)

$71,464,000 (-34.62%)

$109,301,000 (245.34%)

Property Plant & Equipment Net

$11,859,000 (-15.57%)

$14,046,000 (21.54%)

$11,557,000 (538.51%)

$1,810,000 (-39.30%)

Cash & Equivalents

$14,006,000 (-46.19%)

$26,028,000 (97.99%)

$13,146,000 (462.76%)

$2,336,000 (-86.22%)

Accumulated Other Comprehensive Income

-$40,000 (45.95%)

-$74,000 (82.91%)

-$433,000 (-64.64%)

-$263,000 (-511.63%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$61,070,000 (-19.24%)

$75,622,000 (34.64%)

$56,165,000 (-46.80%)

$105,575,000 (616.39%)

Investments Current

$61,070,000 (-19.24%)

$75,622,000 (34.64%)

$56,165,000 (-46.80%)

$105,575,000 (616.39%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$1,736,000 (-28.74%)

$2,436,000 (-79.31%)

$11,775,000 (2606.90%)

$435,000 (-78.67%)

Trade & Non-Trade Payables

$4,323,000 (22.50%)

$3,529,000 (13.62%)

$3,106,000 (201.26%)

$1,031,000 (-27.95%)

Accumulated Retained Earnings (Deficit)

-$532,046,000 (-13.68%)

-$468,023,000 (-12.07%)

-$417,634,000 (-12.18%)

-$372,296,000 (-9.97%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$13,283,000 (-12.00%)

$15,095,000 (30.87%)

$11,534,000 (737.01%)

$1,378,000 (-38.45%)

Debt Current

$1,252,000 (-5.72%)

$1,328,000 (48.55%)

$894,000 (-8.78%)

$980,000 (13.82%)

Debt Non-Current

$12,031,000 (-12.61%)

$13,767,000 (29.39%)

$10,640,000 (2573.37%)

$398,000 (-71.12%)

Total Liabilities

$26,998,000 (-10.55%)

$30,183,000 (23.19%)

$24,502,000 (282.19%)

$6,411,000 (-11.47%)

Liabilities Current

$14,967,000 (-8.83%)

$16,416,000 (18.42%)

$13,862,000 (130.53%)

$6,013,000 (2.54%)

Liabilities Non-Current

$12,031,000 (-12.61%)

$13,767,000 (29.39%)

$10,640,000 (2573.37%)

$398,000 (-71.12%)

ATYR Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$235,000 (-33.43%)

$353,000 (-96.60%)

$10,386,000 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$13,777,000 (6.15%)

$12,979,000 (-7.17%)

$13,982,000 (30.05%)

$10,751,000 (18.47%)

Research & Development Expense

$54,372,000 (28.56%)

$42,293,000 (-1.20%)

$42,808,000 (84.01%)

$23,264,000 (34.54%)

Operating Expenses

$68,149,000 (23.30%)

$55,272,000 (-2.67%)

$56,790,000 (66.96%)

$34,015,000 (29.01%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$64,022,000 (-27.04%)

-$50,397,000 (-11.15%)

-$45,343,000 (-34.24%)

-$33,777,000 (-108.11%)

Net Income to Non-Controlling Interests

$1,000 (112.50%)

-$8,000 (-60.00%)

-$5,000 (44.44%)

-$9,000 (-50.00%)

Net Income

-$64,023,000 (-27.06%)

-$50,389,000 (-11.14%)

-$45,338,000 (-34.26%)

-$33,768,000 (-108.14%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$64,023,000 (-27.06%)

-$50,389,000 (-11.14%)

-$45,338,000 (-34.26%)

-$33,768,000 (-108.14%)

Weighted Average Shares

$74,261,265 (38.53%)

$53,606,488 (88.63%)

$28,419,569 (48.94%)

$19,080,878 (108.30%)

Weighted Average Shares Diluted

$74,261,265 (38.53%)

$53,606,488 (88.63%)

$28,419,569 (48.94%)

$19,080,878 (108.30%)

Earning Before Interest & Taxes (EBIT)

-$64,023,000 (-27.06%)

-$50,389,000 (-11.14%)

-$45,338,000 (-34.26%)

-$33,768,000 (-108.14%)

Gross Profit

$235,000 (-33.43%)

$353,000 (-96.60%)

$10,386,000 (0%)

$0 (0%)

Operating Income

-$67,914,000 (-23.66%)

-$54,919,000 (-18.35%)

-$46,404,000 (-36.42%)

-$34,015,000 (-113.78%)

ATYR Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$17,233,000 (185.62%)

-$20,127,000 (-142.60%)

$47,245,000 (151.60%)

-$91,566,000 (-1427.04%)

Net Cash Flow from Financing

$39,864,000 (-39.81%)

$66,230,000 (1115.01%)

$5,451,000 (-95.05%)

$110,025,000 (581.56%)

Net Cash Flow from Operations

-$69,119,000 (-108.06%)

-$33,221,000 (20.69%)

-$41,886,000 (-26.64%)

-$33,075,000 (-116.16%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$12,022,000 (-193.32%)

$12,882,000 (19.17%)

$10,810,000 (173.96%)

-$14,616,000 (-288.79%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$17,291,000 (208.56%)

-$15,927,000 (-132.70%)

$48,707,000 (153.28%)

-$91,424,000 (-1390.57%)

Capital Expenditure

-$58,000 (98.62%)

-$4,200,000 (-187.28%)

-$1,462,000 (-929.58%)

-$142,000 (22.83%)

Issuance (Repayment) of Debt Securities

-$497,000 (-26.14%)

-$394,000 (-496.97%)

-$66,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$40,361,000 (-39.42%)

$66,624,000 (1107.61%)

$5,517,000 (-94.99%)

$110,025,000 (336.16%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$2,989,000 (14.96%)

$2,600,000 (20.71%)

$2,154,000 (33.46%)

$1,614,000 (10.17%)

Depreciation Amortization & Accretion

$1,540,000 (-43.82%)

$2,741,000 (61.71%)

$1,695,000 (29.98%)

$1,304,000 (3.00%)

ATYR Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00%

-

Profit Margin

-27243.80% (-90.86%)

-14274.50% (-3170.22%)

-436.50%

-

EBITDA Margin

-26588.50% (-96.98%)

-13498.00% (-3112.28%)

-420.20%

-

Return on Average Equity (ROAE)

-85.00% (-71.03%)

-49.70% (8.47%)

-54.30% (-27.76%)

-42.50% (7.00%)

Return on Average Assets (ROAA)

-62.80% (-60.61%)

-39.10% (15.37%)

-46.20% (-17.56%)

-39.30% (-10.39%)

Return on Sales (ROS)

-27243.80% (-90.86%)

-14274.50% (-3170.22%)

-436.50%

-

Return on Invested Capital (ROIC)

-71.60% (-56.67%)

-45.70% (18.54%)

-56.10% (-3.89%)

-54.00% (35.87%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-4.21 (-180.60%)

-1.5 (-9.57%)

-1.37 (67.56%)

-4.22 (-92.52%)

Price to Sales Ratio (P/S)

1,143.94 (434.25%)

214.12 (3472.87%)

5.99

-

Price to Book Ratio (P/B)

4.34 (376.40%)

0.91 (2.47%)

0.89 (-53.19%)

1.9 (53.02%)

Debt to Equity Ratio (D/E)

0.39 (15.92%)

0.33 (-2.92%)

0.34 (481.36%)

0.06 (-74.24%)

Earnings Per Share (EPS)

-0.86 (8.51%)

-0.94 (41.25%)

-1.6 (9.60%)

-1.77 (0.00%)

Sales Per Share (SPS)

0 (-57.14%)

0.01 (-98.08%)

0.36 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.93 (-33.52%)

-0.7 (54.23%)

-1.52 (12.41%)

-1.74 (-3.02%)

Book Value Per Share (BVPS)

0.94 (-44.23%)

1.69 (-32.76%)

2.52 (-56.09%)

5.73 (65.79%)

Tangible Assets Book Value Per Share (TABVPS)

1.3 (-42.07%)

2.25 (-33.20%)

3.37 (-44.34%)

6.05 (43.21%)

Enterprise Value Over EBIT (EV/EBIT)

-5 (-150.00%)

-2 (-100.00%)

-1 (75.00%)

-4 (-100.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-4.85 (-173.39%)

-1.77 (-50.08%)

-1.18 (74.33%)

-4.6 (-158.65%)

Asset Turnover

0 (-33.33%)

0 (-97.17%)

0.11 (0%)

0 (0%)

Current Ratio

5.48 (-12.72%)

6.27 (7.54%)

5.83 (-69.11%)

18.89 (211.72%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$69,177,000 (-84.86%)

-$37,421,000 (13.67%)

-$43,348,000 (-30.50%)

-$33,217,000 (-114.51%)

Enterprise Value (EV)

$303,057,513 (258.44%)

$84,549,686 (63.91%)

$51,583,547 (-65.49%)

$149,460,357 (461.24%)

Earnings Before Tax (EBT)

-$64,023,000 (-27.06%)

-$50,389,000 (-11.14%)

-$45,338,000 (-34.26%)

-$33,768,000 (-108.14%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$62,483,000 (-31.13%)

-$47,648,000 (-9.18%)

-$43,643,000 (-34.44%)

-$32,464,000 (-117.03%)

Invested Capital

$81,140,000 (-13.04%)

$93,304,000 (16.18%)

$80,312,000 (-26.02%)

$108,566,000 (498.19%)

Working Capital

$66,987,000 (-22.63%)

$86,576,000 (29.20%)

$67,009,000 (-37.70%)

$107,556,000 (262.54%)

Tangible Asset Value

$96,830,000 (-19.75%)

$120,653,000 (25.96%)

$95,786,000 (-17.09%)

$115,537,000 (198.34%)

Market Capitalization

$303,871,513 (268.02%)

$82,569,686 (29.97%)

$63,530,547 (-69.40%)

$207,596,357 (428.49%)

Average Equity

$75,354,500 (-25.61%)

$101,291,000 (21.37%)

$83,458,250 (5.11%)

$79,397,750 (123.59%)

Average Assets

$101,909,000 (-20.89%)

$128,826,750 (31.24%)

$98,158,250 (14.28%)

$85,894,000 (88.39%)

Invested Capital Average

$89,363,000 (-18.96%)

$110,275,250 (36.42%)

$80,837,000 (29.34%)

$62,498,750 (224.37%)

Shares

83,942,407 (43.34%)

58,560,061 (101.87%)

29,009,382 (4.39%)

27,790,677 (174.50%)